Login
Navigate Fool.com
Will AMED beat
the market?

Amedisys

NASDAQ: AMED

Community Rating: 2 Stars: Unattractive

13.78 0.03 (0.22%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.75
Previous Close $13.75
Daily Range $13.61 - $13.89
52-Week Range $8.81 - $18.70
Market Cap $450.8M
P/E Ratio -4.61
Dividend (Yield) $0.00 (0.0%)
Volume 219,125
Average Daily Volume 342,979
Current FY EPS -$0.05

How do you think AMED
will perform against the market?

Top AMED Bull/Bear Pitches

 

TMFUltraLong (< 20)
Submitted July 18, 2010

Wow, that only took about a month to completely knock polly off her perch huh? Amedisys has never been a company particularly high up on my buy list largely because home health care companies are pron … More

0 Replies Reply Report this Post
 

abitare (< 20)
Submitted August 9, 2010

<br />Amedisys: Caught Between a RAC and a Hard Place<br />Posted in Citron Reports by CitronResearch on the October 15th, 2009<br /><br /> stock ticker: AMED<br />&nbsp;&nbsp;&nbsp;<br />Citron first … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

3 Horrendous Health-Care Stocks This Week

Sarepta, Epizyme, and Amedisys round out this week's worst-performing health-care stocks.

Pre-Market Earnings Report for March 12, 2014 : DRC, EXPR, RAVN, AMED, AXAS, BWEN, TAOM

Pre-Market Earnings Report for March 12, 2014 : DRC, EXPR, RAVN, AMED, AXAS, BWEN, TAOM

KKR adds to Amedisys position

Insiders Buy Shares at Amedisys and Nexpoint Credit Strategies Fund

Insiders at Agco, Amedisys, and Mellanox Technologies Buy Shares

Plus, a purchase at Accuride.

Insiders at Agco, Amedisys, and Mellanox Technologies Buy Shares

Why Sarepta Therapeutics, Amedisys, and Hanwha SolarOne Dropped With the Dow Today

The Dow Jones Industrials dropped 32 points as investors remain nervous about the bull market's sustainability, but those losses paled in comparison to Sarepta Therapeutics' 64% drop, Amedisys' loss of 17%, and Hanwha SolarOne's 14% decline. Get the scoop on why these stocks sank today.

Why Amedisys Inc. Shares Plunged

Is this meaningful? Or just another movement?

Medtronic's Plan to Reduce Hospital Readmissions

The Affordable Care Act is creating a variety of challenges and opportunities for health care companies. Medtronic is embracing a provision designed to reduce re-admissions by expanding into the home monitoring market.

Top Analyst Upgrades and Downgrades: ARM, Crocs, GE, NOV and More

See More AMED News...

Sector

Healthcare

Industry

Healthcare Information Services

Amedisys (AMED) Description

The Company is a multi-state provider of home health and hospice services. Website: http://www.amedisys.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks